Evidence map›Paper›PMID 15150247›Full record

ArticleJournal of bacteriology2004

Methionine sulfoxide reductase A (MsrA) deficiency affects the survival of Mycobacterium smegmatis within macrophages.

T Douglas, D S Daniel, B K Parida, C Jagannath, S Dhandayuthapani

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. HEmerging microbes & infections · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Identification ofFrontiers in cellular and infection microbiology · 2016
    Article
  14. Article
  15. Article
  16. Methionine oxidation and reduction in proteins.Biochimica et biophysica acta · 2014
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

T DouglasDepartment of Microbiology and Immunology, University of Texas Health Science Center, San Antonio, Texas 78229, USA.
D S Daniel
B K Parida
C Jagannath
S Dhandayuthapani
The University of Texas Health Science Center at San Antonio · USThe University of Texas Health Science Center at Houston · US

Funding

Chracteristics of An M. Tuberculosis Derived VaccineR01AI049534 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI JAGANNATH, CHINNASWAMY · 2002 to 2011
$3.4M
NIAID NIH HHS AI49534NIAID NIH HHS R01 AI049534
6 · The paper itself

Abstract

Methionine sulfoxide reductase A (MsrA) is an antioxidant repair enzyme which reduces oxidized methionine to methionine. Since oxidation of methionine in proteins impairs their function, an absence of MsrA leads to abnormalities in different organisms, including alterations in the adherence patterns and in vivo survival of certain pathogenic bacteria. To understand the role of MsrA in intracellular survival of bacteria, we disrupted the gene encoding MsrA in Mycobacterium smegmatis through homologous recombination. The msrA mutant strain of M. smegmatis exhibited significantly reduced intracellular survival in murine J774A.1 macrophages compared to the survival of its wild-type counterpart. Furthermore, immunofluorescence and immunoblotting of phagosomes containing M. smegmatis strains revealed that the phagosomes with the msrA mutant strain acquired both p67(phox) of phagocyte NADPH oxidase and inducible nitric oxide synthase much earlier than the phagosomes with the wild-type strain. In addition, the msrA mutant strain of M. smegmatis was observed to be more sensitive to hydroperoxides than the wild-type strain was in vitro. These results suggest that MsrA plays an important role in both extracellular and intracellular survival of M. smegmatis.

Indexed as

AnimalsBacterial ProteinsCell LineFluorescent Antibody TechniqueFree RadicalsGenome, BacterialMacrophagesMembrane Transport ProteinsMiceMutationMycobacterium smegmatisNitric Oxide SynthaseNitric Oxide Synthase Type IIOxidative StressPhagosomesPhosphoproteinsBacterial ProteinsFree RadicalsMembrane Transport ProteinsmsrA protein, Staphylococcus epidermidisneutrophil cytosol factor 67KNitric Oxide SynthaseNitric Oxide Synthase Type IINos2 protein, mousePhosphoproteins

Identifiers

PMID15150247
PMCPMC415777
OpenAlexW1972734295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.